HRP20010285A2 - Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor - Google Patents
Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitorInfo
- Publication number
- HRP20010285A2 HRP20010285A2 HR20010285A HRP20010285A HRP20010285A2 HR P20010285 A2 HRP20010285 A2 HR P20010285A2 HR 20010285 A HR20010285 A HR 20010285A HR P20010285 A HRP20010285 A HR P20010285A HR P20010285 A2 HRP20010285 A2 HR P20010285A2
- Authority
- HR
- Croatia
- Prior art keywords
- inhibitor
- controlled
- pharmaceutical formulations
- formulations containing
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823192.1A GB9823192D0 (en) | 1998-10-23 | 1998-10-23 | Pharmaceutical formulations |
GBGB9825117.6A GB9825117D0 (en) | 1998-11-16 | 1998-11-16 | Pharmaceutical formulations |
GBGB9826392.4A GB9826392D0 (en) | 1998-11-27 | 1998-11-27 | Pharmaceutical formulations |
PCT/IB1999/001619 WO2000024383A1 (en) | 1998-10-23 | 1999-10-04 | Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20010285A2 true HRP20010285A2 (en) | 2002-06-30 |
Family
ID=27269526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20010285A HRP20010285A2 (en) | 1998-10-23 | 2001-04-19 | Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
Country Status (44)
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2295436A1 (de) * | 1997-11-12 | 2011-03-16 | Bayer Schering Pharma AG | 2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase V Inhibitoren |
CA2348871C (en) | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
CA2420461C (en) | 2000-09-06 | 2008-08-12 | Tanabe Seiyaku Co., Ltd. | Preparations for oral administration |
EP1337244A4 (en) | 2000-10-30 | 2006-01-11 | Euro Celtique Sa | HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE |
DE60236850D1 (de) * | 2001-02-15 | 2010-08-12 | Mitsubishi Tanabe Pharma Corp | Tabletten, die in der mundhöhle schnell zerfallen |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
ITMI20020515A1 (it) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | Sistema per il rilasco controllato di uno o piu' principi attivi |
GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
JP2007537247A (ja) | 2004-05-11 | 2007-12-20 | エモーショナル ブレイン ビー.ブイ. | 女性性的機能不全の治療における薬学的製剤およびその使用方法 |
DE102004023069A1 (de) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
GB0421121D0 (en) * | 2004-09-22 | 2004-10-27 | Natrocell Technologies Ltd | Composite rodenticide |
DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
WO2007000764A2 (en) * | 2005-06-27 | 2007-01-04 | Daniel Drai | Compositions and methods for enhancement of sexual function |
PL1912650T3 (pl) | 2005-08-03 | 2018-01-31 | Sprout Pharmaceuticals Inc | Zastosowanie flibanseryny w leczeniu otyłości |
KR20080056250A (ko) * | 2005-09-29 | 2008-06-20 | 바이엘 헬스케어 아게 | 비뇨기 장애의 치료를 위한 pde 억제제 및 이들의 조합 |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
EP1790343A1 (en) * | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
JP2009541443A (ja) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 尿失禁及び関連疾患の治療のためのフリバンセリン |
JP5793828B2 (ja) | 2006-08-14 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | フリバンセリンの製剤及びその製造方法 |
EP2056797A2 (en) | 2006-08-25 | 2009-05-13 | Boehringer Ingelheim International GmbH | Controlled release system and method for manufacturing the same |
EP1925307A1 (en) * | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
US20080226715A1 (en) * | 2007-03-16 | 2008-09-18 | Albert Cha | Therapeutic compositions and methods |
CN101711153A (zh) * | 2007-06-13 | 2010-05-19 | 拜耳先灵制药股份公司 | 用于治疗听觉损伤的pde抑制剂 |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
WO2009098697A1 (en) * | 2008-02-08 | 2009-08-13 | Dexxon Ltd. | Modafinil and sildenafil dosage forms |
EP2374460A4 (en) * | 2008-12-12 | 2013-08-21 | Rhein Siegfried Sa De Cv | SILDENAFIL COMPOSITION WITH PULSED RELEASE AND METHOD FOR PRODUCING THIS COMPOSITION |
KR101004205B1 (ko) * | 2008-12-17 | 2010-12-24 | 동아제약주식회사 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
EA015250B9 (ru) * | 2010-11-19 | 2013-10-30 | Тева Фармасьютикал Индастриз, Лтд. | Таблетка силденафила, обеспечивающая модифицированную фармакокинетику, и способ ее изготовления |
BR112013029199B1 (pt) | 2011-05-13 | 2022-02-08 | Eb Ip Hybritabs B.V. | Dispositivo de distribuição de dois fármacos |
WO2013016144A1 (en) * | 2011-07-22 | 2013-01-31 | Pom Wonderful, Llc | Compositions comprising pomegranate polyphenols in combination with erectile dysfunction-treating compounds, and methods of treating erectile dysfunction therewith |
WO2017168174A1 (en) * | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
CN113995727B (zh) * | 2021-11-08 | 2023-04-07 | 山东鲁抗医药股份有限公司 | 一种5型磷酸二酯酶抑制剂片剂及其制备方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3952741A (en) | 1975-01-09 | 1976-04-27 | Bend Research Inc. | Controlled release delivery system by an osmotic bursting mechanism |
JPS54119021A (en) * | 1978-03-06 | 1979-09-14 | Nippon Kayaku Co Ltd | Carcinostatic agent |
CH648754A5 (en) * | 1979-08-16 | 1985-04-15 | Ciba Geigy Ag | Pharmaceutical slow release tablet |
JPS5748908A (en) * | 1980-09-08 | 1982-03-20 | Kyorin Pharmaceut Co Ltd | Prolonged release type nicomol pharmaceutical |
FR2624732B1 (fr) | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
IT1229856B (it) * | 1989-04-20 | 1991-09-13 | Recordati Chem Pharm | Compresse a rilascio controllato contenenti flavossato. |
US5474784A (en) | 1990-03-02 | 1995-12-12 | British Technology Group Limited | Dispensing device |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
PT621032E (pt) * | 1993-04-23 | 2001-01-31 | Novartis Ag | Dispositivo de distribuicao de libertacao controlada de farmaco |
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
US5464633A (en) | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
US5656629A (en) * | 1995-03-10 | 1997-08-12 | Sanofi Winthrop, Inc. | 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof |
US5888534A (en) | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
JPH1067657A (ja) * | 1996-06-18 | 1998-03-10 | Otsuka Pharmaceut Co Ltd | マルチプルユニット型持続性製剤 |
WO1997048382A2 (en) * | 1996-06-18 | 1997-12-24 | Otsuka Pharmaceutical Co., Ltd. | Multiple-unit type prolonged action drug preparation |
DK0941075T3 (da) * | 1997-01-06 | 2003-07-14 | Pfizer | Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6277884B1 (en) * | 1998-06-01 | 2001-08-21 | Nitromed, Inc. | Treatment of sexual dysfunction with N-hydroxyguanidine compounds |
DK1109814T3 (da) * | 1998-09-04 | 2004-08-02 | Ortho Mcneil Pharm Inc | 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion |
-
1999
- 1999-04-10 UA UA2001042718A patent/UA67802C2/uk unknown
- 1999-10-01 TW TW088116973A patent/TW577756B/zh not_active IP Right Cessation
- 1999-10-04 ID IDW20010891A patent/ID28232A/id unknown
- 1999-10-04 EE EEP200100235A patent/EE200100235A/xx unknown
- 1999-10-04 CZ CZ20011427A patent/CZ20011427A3/cs unknown
- 1999-10-04 AT AT99946377T patent/ATE340562T1/de not_active IP Right Cessation
- 1999-10-04 AP APAP/P/2001/002125A patent/AP2001002125A0/en unknown
- 1999-10-04 DK DK99946377T patent/DK1123088T3/da active
- 1999-10-04 IL IL141764A patent/IL141764A/en unknown
- 1999-10-04 AU AU58787/99A patent/AU756509B2/en not_active Ceased
- 1999-10-04 SK SK519-2001A patent/SK286473B6/sk unknown
- 1999-10-04 KR KR1020017005042A patent/KR20010075659A/ko not_active Application Discontinuation
- 1999-10-04 EP EP99946377A patent/EP1123088B1/en not_active Expired - Lifetime
- 1999-10-04 WO PCT/IB1999/001619 patent/WO2000024383A1/en active IP Right Grant
- 1999-10-04 OA OA1200100093A patent/OA11664A/en unknown
- 1999-10-04 TR TR2001/01103T patent/TR200101103T2/xx unknown
- 1999-10-04 NZ NZ510275A patent/NZ510275A/en unknown
- 1999-10-04 EA EA200100298A patent/EA004068B1/ru not_active IP Right Cessation
- 1999-10-04 JP JP2000577993A patent/JP2002528408A/ja active Pending
- 1999-10-04 HU HU0104318A patent/HUP0104318A3/hu unknown
- 1999-10-04 ES ES99946377T patent/ES2272082T3/es not_active Expired - Lifetime
- 1999-10-04 CN CN99812510A patent/CN1324233A/zh active Pending
- 1999-10-04 PT PT99946377T patent/PT1123088E/pt unknown
- 1999-10-04 DE DE69933383T patent/DE69933383T2/de not_active Expired - Fee Related
- 1999-10-04 PL PL99347476A patent/PL195789B1/pl not_active IP Right Cessation
- 1999-10-04 CA CA002348086A patent/CA2348086C/en not_active Expired - Fee Related
- 1999-10-04 MX MXPA01004011A patent/MXPA01004011A/es active IP Right Grant
- 1999-10-04 BR BR9914718-1A patent/BR9914718A/pt not_active Application Discontinuation
- 1999-10-18 PA PA19998484301A patent/PA8484301A1/es unknown
- 1999-10-20 MY MYPI99004535A patent/MY130727A/en unknown
- 1999-10-20 DZ DZ990223A patent/DZ2923A1/xx active
- 1999-10-20 MA MA25820A patent/MA26700A1/fr unknown
- 1999-10-21 PE PE1999001062A patent/PE20001286A1/es not_active Application Discontinuation
- 1999-10-22 GT GT199900184A patent/GT199900184A/es unknown
- 1999-10-22 CO CO99066970A patent/CO5160262A1/es unknown
- 1999-10-22 US US09/425,622 patent/US6964780B1/en not_active Expired - Fee Related
- 1999-10-22 UY UY25765A patent/UY25765A1/es not_active Application Discontinuation
-
2001
- 2001-02-27 IS IS5865A patent/IS5865A/is unknown
- 2001-03-14 CR CR6326A patent/CR6326A/es not_active Application Discontinuation
- 2001-04-19 NO NO20011933A patent/NO20011933L/no not_active Application Discontinuation
- 2001-04-19 HR HR20010285A patent/HRP20010285A2/xx not_active Application Discontinuation
- 2001-04-24 BG BG105465A patent/BG65323B1/bg unknown
-
2002
- 2002-05-13 HK HK02103588.0A patent/HK1041818A1/zh unknown
-
2006
- 2006-11-13 CY CY20061101644T patent/CY1106239T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141764A0 (en) | Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor | |
IL110014A0 (en) | Solid controlled-release oral dosage forms | |
ZA983402B (en) | Bioadhesive tablets | |
HUP0002469A3 (en) | Solid thermoformable controlled-release pharmaceutical composition | |
GB9713149D0 (en) | Pharmaceutical formulations | |
SG79255A1 (en) | Pharmaceutical formulations | |
EP0956854A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING KOENZYM Q-10 | |
ZA981622B (en) | Radiation-curable cyanoacrylate-containing compositions | |
PL334959A1 (en) | Film-coated oxacarbazepin tablets | |
HUP0400644A3 (en) | Pharmaceutical compositions containing aspirin | |
PL339461A1 (en) | Orally administered compositions containing levosimendane | |
EP1003495A4 (en) | PHARMACEUTICAL COMPOUNDS | |
GB0110612D0 (en) | Controlled-release garlic formulations | |
IL131917A (en) | Pharmaceutical compositions containing lamivudine | |
CY2293B1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
GB9725219D0 (en) | Tablets | |
IL128107A0 (en) | Pharmaceutical compositions containing a pkc inhibitor | |
IL131039A0 (en) | Oxacarbazepine film-coated tablets | |
SI0966287T1 (en) | Oxacarbazepine film-coated tablets | |
GB9703607D0 (en) | Pharmaceutical formulations | |
SI0906101T1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
GB9816558D0 (en) | Pharmaceutical formulations | |
GB9828205D0 (en) | Pharmaceutical formulations | |
GB9823192D0 (en) | Pharmaceutical formulations | |
GB9820837D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
OBST | Application withdrawn |